바이러스 벡터 및 플라스미드 DNA 제조 시장 : 제품 유형별, 워크플로우별, 용도별, 최종 용도별, 국가별, 지역별 - 업계 분석, 시장 규모, 시장 점유율 및 예측(2026-2033년)

Viral Vectors and Plasmid DNA Manufacturing Market size was valued at USD 6,590.2 Million in 2025, expanding to a CAGR of 15.1% from 2026 to 2033.

Viral vectors and plasmid DNA manufacturing involves creating specialized genetic materials that support the development of gene-therapies, cell-based treatments, vaccines, and other advanced biomedical applications. Plasmid DNA acts as a carrier of genetic instructions and often assists as the foundation for producing viral vectors. Viral vectors are carefully engineered viruses designed to transport therapeutic genes into specific cells while minimizing the risk of causing illness.

Viral Vectors and Plasmid DNA Manufacturing Market- Market Dynamics

Growing advancement in cell therapies, gene therapies, next-gen vaccines and adoption of automated manufacturing processes are expected to propel market demand

Development of gene-based therapies, cell-based therapies and advanced vaccine technologies are the major driving factors for Viral Vectors and Plasmid DNA Manufacturing Market. The demand for reliable viral vectors and plasmid DNA is still growing, as biotechnological and pharmaceutical companies focus on developing precision medicines that target diseases through genetic modification and targeted intervention. These products are basic tools for transfection of cells with genetic material and the development of new therapeutic solutions and are indispensable to the development of modern biopharmaceutical research and production. According to the genomic research studies, more than 2,000 gene and cell therapy candidates are currently being evaluated across various stages of clinical development globally, creating significant demand for viral vectors and plasmid DNA production.

To speed up manufacturing cycles, minimize contamination risks and streamline operations, companies are increasingly using automated production platforms, single-use processing equipment and advanced purification technologies. Moreover, contract development and manufacturing organizations (CDMOs) are expanding production capacity through facility upgrades, new investments, and strategic collaborations to support the growing outsourcing needs of biotechnology and pharmaceutical companies. Manufacturers are also advancing the development of next-generation viral vectors designed to offer greater safety, improved targeting capabilities, and enhanced gene delivery efficiency. Further, as biotechnology and pharmaceutical companies focus on developing precision medicines that address diseases through genetic modification and targeted intervention, the need for reliable viral vectors and plasmid DNA continues to rise. The market is therefore expected to maintain strong momentum, supported by ongoing innovation and expanding therapeutic applications.

Viral Vectors and Plasmid DNA Manufacturing Market- Segmentation Analysis:

The Global Viral Vectors and Plasmid DNA Manufacturing Market is segmented on the basis of Product Type, Workflow, Application, End-Use, and Region.

The market is divided into two categories based on Product Type: viral vectors and plasmid DNA. Viral vectors segment anticipated to hold significant revenue share in the product type. Viral vectors are the primary delivery vehicles used in cell therapy, gene therapy, and several advanced vaccine platforms. viral vectors perform the essential function of transporting therapeutic genes into target cells, making them indispensable in clinical solutions.

Viral Vectors and Plasmid DNA Manufacturing Market- Geographical Insights

The viral vectors and plasmid DNA manufacturing market exhibits robust regional expansion, with North America holding a predominant share owing to its mature biotechnology industry, strong presence of advanced therapy developers, extensive research activities, and substantial investments in gene and cell therapy programs. Europe remains a significant market, driven by rising investments in advanced therapeutic technologies, increasing biopharmaceutical manufacturing capabilities, and stronger cooperation between academic institutions, research centers, and industry participants. In the Asia-Pacific region, market growth is being fueled by the construction of new GMP-certified production facilities, the rapid expansion of contract development and manufacturing organizations (CDMOs), and the integration of advanced automation technologies into manufacturing processes.

Canada Viral Vectors and Plasmid DNA Manufacturing Market- Key Insights

Canada is emerging as an important region in the viral vectors and plasmid DNA manufacturing market due to its expanding biotechnology sector, strong research capabilities, and increasing investments in advanced therapeutics. The growing focus on localizing the supply chain for advanced therapies. Organizations are investing in automation, digital manufacturing systems, and scalable production platforms to improve efficiency and reduce dependence on external suppliers. In addition, collaborations between biotechnology firms, research institutions, and healthcare organizations are accelerating innovation and technology transfer. Thus, growing activity in gene-therapy, cell therapy, and vaccine development are generating huge demand for high-quality viral vectors.

Viral Vectors and Plasmid DNA Manufacturing Market- Competitive Landscape:

The competitive landscape of the viral vectors and plasmid DNA manufacturing market is characterized by the expansion of capabilities among biotech companies, specialized manufacturers and contract development and manufacturing organizations (CDMOs) to cater to the rapidly growing field of advanced therapies. Industry players are investing in new manufacturing facilities, upgrading their existing GMP compliant sites and adopting advanced production technologies that improve scalability and efficiency to strengthen their market position. Many organizations are also boosting their manufacturing capacity through strategic partnerships, acquisitions, and biotech company agreements. As more therapies move toward commercialization, the expectation is that there will be a need for reliable, large-scale viral vector and plasmid DNA manufacturing services, which will drive healthy competition.

Recent Developments:

In March 2025, WuXi Biologics introduced the EffiX(TM) microbial expression platform, an advanced high-productivity technology developed to optimize recombinant protein and plasmid DNA production. The platform was designed to improve manufacturing yields, enhance process scalability.

In June 2025, ProBio inaugurated its new 128,000-square-foot Cell and Gene Therapy Center of Excellence in Hopewell, New Jersey. The GMP-compliant facility was established to expand the company's manufacturing capabilities for plasmid DNA, adeno-associated virus (AAV) vectors, and lentiviral vectors, enabling greater support for clinical programs.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET KEY PLAYERS

• Lonza
• Aldevron
• ViroCell Biologics
• Andelyn Biosciences
• VGXI, Inc.
• Avid Bioservices
• Thermo Fisher Scientific
• WuXi Biologics
• Catalent Inc.
• AGC Biologics
• Fujifilm Diosynth Biotechnologies
• Cobra Biologics
• Oxford Biomedica
• Takara Bio
• Charles River Laboratories
• Merck KGaA
• Sartorius
• GenScript Biotech
• RegenxBio Inc.
• SIRION Biotech
• Others

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020-2033

• Viral Vectors
• Adeno-Associated Virus (AAV)
• Lentivirus
• Adenovirus
• Retrovirus
• Plasmid DNA
• Research-Grade Plasmid DNA
• GMP-Grade Plasmid DNA

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY WORKFLOW- MARKET ANALYSIS, 2020-2033

• Upstream Manufacturing
• Downstream Manufacturing

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

• Cell Therapy
• Gene Therapy
• Vaccine Development
• Others

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY END-USE- MARKET ANALYSIS, 2020-2033

• Pharmaceutical & Biotechnology Companies
• CDMOs
• Academic & Research Institutes
• Others

GLOBAL VIRAL VECTORS AND PLASMID DNA MANUFACTURING MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC
• Latin America
• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM
• The Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA

Table of Contents

1. Viral Vectors and Plasmid DNA Manufacturing Market Overview

• 1.1. Study Scope
• 1.2. Market Estimation Years

2. Executive Summary

• 2.1. Market Snippet
  • 2.1.1. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Product Type
  • 2.1.2. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Workflow
  • 2.1.3. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Application
  • 2.1.4. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by End-Use
  • 2.1.5. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Country
  • 2.1.6. Viral Vectors and Plasmid DNA Manufacturing Market Snippet by Region
• 2.2. Competitive Insights

3. Viral Vectors and Plasmid DNA Manufacturing Key Market Trends

• 3.1. Viral Vectors and Plasmid DNA Manufacturing Market Drivers
  • 3.1.1. Impact Analysis of Market Drivers
• 3.2. Viral Vectors and Plasmid DNA Manufacturing Market Restraints
  • 3.2.1. Impact Analysis of Market Restraints
• 3.3. Viral Vectors and Plasmid DNA Manufacturing Market Opportunities
• 3.4. Viral Vectors and Plasmid DNA Manufacturing Market Future Trends

4. Viral Vectors and Plasmid DNA Manufacturing Industry Study

• 4.1. PEST Analysis
• 4.2. Porter's Five Forces Analysis
• 4.3. Growth Prospect Mapping
• 4.4. Regulatory Framework Analysis

5. Viral Vectors and Plasmid DNA Manufacturing Market: Impact of Escalating Geopolitical Tensions

• 5.1. Impact of COVID-19 Pandemic
• 5.2. Impact of Russia-Ukraine War
• 5.3. Impact of Middle East Conflicts

6. Viral Vectors and Plasmid DNA Manufacturing Market Landscape

• 6.1. Viral Vectors and Plasmid DNA Manufacturing Market Share Analysis, 2025
• 6.2. Breakdown Data, by Key Manufacturer
  • 6.2.1. Established Players' Analysis
  • 6.2.2. Emerging Players' Analysis

7. Viral Vectors and Plasmid DNA Manufacturing Market - By Product Type

• 7.1. Overview
  • 7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
  • 7.1.2. Viral Vectors
    • 7.1.2.1. Adeno-Associated Virus (AAV)
    • 7.1.2.2. Lentivirus
    • 7.1.2.3. Adenovirus
    • 7.1.2.4. Retrovirus
  • 7.1.3. Plasmid DNA
    • 7.1.3.1. Research-Grade Plasmid DNA
    • 7.1.3.2. GMP-Grade Plasmid DNA

8. Viral Vectors and Plasmid DNA Manufacturing Market - By Workflow

• 8.1. Overview
  • 8.1.1. Segment Share Analysis, By Workflow, 2025 & 2033 (%)
  • 8.1.2. Upstream Manufacturing
  • 8.1.3. Downstream Manufacturing

9. Viral Vectors and Plasmid DNA Manufacturing Market - By Application

• 9.1. Overview
  • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
  • 9.1.2. Cell Therapy
  • 9.1.3. Gene Therapy
  • 9.1.4. Vaccine Development
  • 9.1.5. Others

10. Viral Vectors and Plasmid DNA Manufacturing Market - By End-Use

• 10.1. Overview
  • 10.1.1. Segment Share Analysis, By End-Use, 2025 & 2033 (%)
  • 10.1.2. Pharmaceutical & Biotechnology Companies
  • 10.1.3. CDMOs
  • 10.1.4. Academic & Research Institutes
  • 10.1.5. Others

11. Viral Vectors and Plasmid DNA Manufacturing Market- By Geography

• 11.1. Introduction
  • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
• 11.2. North America
  • 11.2.1. Overview
  • 11.2.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in North America
  • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.2.5. North America Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.2.7. North America Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.2.8. U.S.
    • 11.2.8.1. Overview
    • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.8.4. U.S. Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.8.6. U.S. Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.2.9. Canada
    • 11.2.9.1. Overview
    • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.2.9.4. Canada Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.9.6. Canada Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.3. Europe
  • 11.3.1. Overview
  • 11.3.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Europe
  • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.3.5. Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.3.7. Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.8. Germany
    • 11.3.8.1. Overview
    • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.8.4. Germany Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.8.6. Germany Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.9. UK
    • 11.3.9.1. Overview
    • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.9.4. UK Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.9.6. UK Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.10. France
    • 11.3.10.1. Overview
    • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.10.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.10.4. France Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.10.6. France Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.11. Italy
    • 11.3.11.1. Overview
    • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.11.4. Italy Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.11.6. Italy Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.12. Spain
    • 11.3.12.1. Overview
    • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.12.4. Spain Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.12.6. Spain Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.13. The Netherlands
    • 11.3.13.1. Overview
    • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.13.4. The Netherlands Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.13.6. The Netherlands Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.14. Sweden
    • 11.3.14.1. Overview
    • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.14.4. Sweden Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.14.6. Sweden Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.15. Russia
    • 11.3.15.1. Overview
    • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.15.4. Russia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.15.6. Russia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.16. Poland
    • 11.3.16.1. Overview
    • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.16.4. Poland Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.16.6. Poland Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.3.17. Rest of Europe
    • 11.3.17.1. Overview
    • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.4. Asia Pacific (APAC)
  • 11.4.1. Overview
  • 11.4.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Asia Pacific
  • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.4.5. APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.4.7. APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.8. China
    • 11.4.8.1. Overview
    • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.8.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.8.4. China Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.8.6. China Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.9. India
    • 11.4.9.1. Overview
    • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.9.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.9.4. India Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.9.6. India Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.10. Japan
    • 11.4.10.1. Overview
    • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.10.4. Japan Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.10.6. Japan Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.11. South Korea
    • 11.4.11.1. Overview
    • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.11.4. South Korea Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.11.6. South Korea Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.12. Australia
    • 11.4.12.1. Overview
    • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.12.4. Australia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.12.6. Australia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.13. Indonesia
    • 11.4.13.1. Overview
    • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.13.4. Indonesia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.13.6. Indonesia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.14. Thailand
    • 11.4.14.1. Overview
    • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.14.4. Thailand Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.14.6. Thailand Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.15. Philippines
    • 11.4.15.1. Overview
    • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.15.4. Philippines Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.15.6. Philippines Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.4.16. Rest of APAC
    • 11.4.16.1. Overview
    • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.4.16.4. Rest of APAC Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.5. Latin America (LATAM)
  • 11.5.1. Overview
  • 11.5.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Latin America
  • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.5.5. LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.5.7. LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.8. Brazil
    • 11.5.8.1. Overview
    • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.8.4. Brazil Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.8.6. Brazil Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.9. Mexico
    • 11.5.9.1. Overview
    • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.9.4. Mexico Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.9.6. Mexico Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.10. Argentina
    • 11.5.10.1. Overview
    • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.10.4. Argentina Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.10.6. Argentina Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.11. Colombia
    • 11.5.11.1. Overview
    • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.11.4. Colombia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.11.6. Colombia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.5.12. Rest of LATAM
    • 11.5.12.1. Overview
    • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
• 11.6. Middle East and Africa (MEA)
  • 11.6.1. Overview
  • 11.6.2. Viral Vectors and Plasmid DNA Manufacturing Key Manufacturers in Middle East and Africa
  • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
  • 11.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
  • 11.6.5. MEA Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
  • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
  • 11.6.7. MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.8. Saudi Arabia
    • 11.6.8.1. Overview
    • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.9. United Arab Emirates
    • 11.6.9.1. Overview
    • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.10. Israel
    • 11.6.10.1. Overview
    • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.10.4. Israel Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.10.6. Israel Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.11. Turkey
    • 11.6.11.1. Overview
    • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.11.4. Turkey Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.11.6. Turkey Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.12. Algeria
    • 11.6.12.1. Overview
    • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.12.4. Algeria Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.12.6. Algeria Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.13. Egypt
    • 11.6.13.1. Overview
    • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.13.4. Egypt Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.13.6. Egypt Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)
  • 11.6.14. Rest of MEA
    • 11.6.14.1. Overview
    • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
    • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
    • 11.6.14.4. Rest of MEA Market Size and Forecast, By Workflow, 2020 - 2033 (US$ Million)
    • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Use, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Viral Vectors and Plasmid DNA Manufacturing Industry

• 12.1. Competitive Dashboard
  • 12.1.1. Competitive Benchmarking
  • 12.1.2. Competitive Positioning
• 12.2. Company Profiles
  • 12.2.1. Lonza
  • 12.2.2. Aldevron
  • 12.2.3. ViroCell Biologics
  • 12.2.4. Andelyn Biosciences
  • 12.2.5. VGXI, Inc.
  • 12.2.6. Avid Bioservices
  • 12.2.7. Thermo Fisher Scientific
  • 12.2.8. WuXi Biologics
  • 12.2.9. Catalent Inc.
  • 12.2.10. AGC Biologics
  • 12.2.11. Fujifilm Diosynth Biotechnologies
  • 12.2.12. Cobra Biologics
  • 12.2.13. Oxford Biomedica
  • 12.2.14. Takara Bio
  • 12.2.15. Charles River Laboratories
  • 12.2.16. Merck KGaA
  • 12.2.17. Sartorius
  • 12.2.18. GenScript Biotech
  • 12.2.19. RegenxBio Inc.
  • 12.2.20. SIRION Biotech
  • 12.2.21. Others

13. 360 Degree AnalystView

14. Appendix

• 14.1. Research Methodology
• 14.2. References
• 14.3. Abbreviations
• 14.4. Disclaimer
• 14.5. Contact Us